Infinite Biomedical Technologies

Infinite Biomedical Technologies (IBT) is a medical device company established in 1997 and rooted at Johns Hopkins University, specializing in innovative solutions for upper limb loss and difference. The company develops myoelectric control systems and related prosthetic technologies designed to improve patient outcomes and functionality. IBT's primary product lines include Glide, an advanced myoelectric control system, and FlexCell, a flexible battery system for prosthetic devices. The company has demonstrated significant clinical validation, with over 50 peer-reviewed publications in the medical literature and more than 5,000 patients served globally across 21 countries. IBT holds 9 patents and has received 55 awarded grants, reflecting substantial investment in research and development. The company's focus on streamlined, user-centered design suggests commitment to accessibility and ease of use for patients with upper limb loss. As a Johns Hopkins-affiliated organization, IBT operates within a research-intensive environment emphasizing evidence-based product development.